Tuberculin testing to detect latent tuberculosis in developing countries

Epidemiology

Volumn 18, Issue 3, 2007, Pages 348-349

  Nelson, Kenrad ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID;

BCG VACCINATION; CYTOKINE RELEASE; DEVELOPING COUNTRY; DISEASE CONTROL; EPIDEMIC; GUINEA-BISSAU; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SHORT COURSE THERAPY; TUBERCULIN TEST; TUBERCULOSIS;

AGE FACTORS; BCG VACCINE; DEVELOPING COUNTRIES; DIRECTLY OBSERVED THERAPY; ENVIRONMENTAL EXPOSURE; GUINEA-BISSAU; HIV INFECTIONS; HUMANS; PREVALENCE; RESIDENCE CHARACTERISTICS; SEX FACTORS; SOCIOECONOMIC FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 34247218126     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000259985.76928.64     Document Type: Review

References (15)

1. Gustafson P, Lisse I, Gomes V, et al. Risk factors for positive tuberculin skin test in Guinea-Bissau. Epidemiology. 2007;18:339-346.
2. Hirsch-Moverman Y, Tsiouris S, Salazar-Schicchi J, et al. Physician attitudes regarding latent tuberculosis infection, international vs. US medical graduates. Int J Tuberc Lung Dis. 2006;10:1178-1180.
3. Hiransuthikul N, Hiransuthikul P, Nelson KE, et al. Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand. Southeast Asian J Trop Med Public Health. 2005;36:1208-1215.
4. Chariyalertsak S, Sirisanthana T, Saengwonloey O, et al. Clinical presentation and risk behaviors of AIDS patients in Thailand 1994-1998, regional variation and temporal trends. Clin Infect Dis. 2001;32:955-962.
5. UNAIDS. Report on the Global AIDS Epidemic. Geneva, Switzerland: WHO; 2005.
6. Siriarayapon P, Yanai H, Glynn JR, et al. The evolving epidemiology of HIV infection and tuberculosis in Northern Thailand. J Acquir Immune Defic Dis. 2002;31:80-89.
7. Department of Communicable Disease Control, MOPH, Thailand and World Health organization. Second Review of the National Tuberculosis Program in Thailand. Bangkok, Thailand: Ministry of Public Health; 1999.
8. DeRiemer K, Daley CL, Reingold AL. Preventing tuberculosis among HIV-infected persons: a survey of physicians knowledge and practices. Prev Med. 1999;28:437-444.
9. DeCock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis. 1999;3:457-465.
10. Kenyon TA, Mwasekaga MJ, Huebner R, et al. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis. 1999;3:4-11.
11. Hiransuthikul N, Nelson KE, Hiransuthikul P, et al. INH preventive therapy among adult HIV-infected patients in Thailand. Int J Tuberc Lung Dis. 2005;9:270-275.
12. Ngamvithayapong J, Uthaivoravit W, Yanai H, et al. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand. AIDS. 2007;11:107-112.
13. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV-infected persons. Cochrane Database of Syst Rev. 2006.
14. Smieja MJ, Marchetti CA, Cook DJ, et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database of Syst Rev. 1999:CD001363.
15. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:761-776.